03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Zoledronic Acid Hikma : | |
Type | Medicine Non Marketed |
Originator | Zometa |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | Hikma Pharmaceuticals |
Responsible Party | Hikma Pharmaceuticals |
Origin | Jordan |
Manufacturer | Hikma Pharmaceuticals PLC |
Manufacturing Type | G |
Origin | Jordan |
ATC | M05BA08 |
Zoledronic Acid Hikma :
Zoledronic Acid Hikma :
Zoledronic Acid Hikma :
Zoledronic Acid Hikma :
Zoledronic Acid Hikma :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Zoledronic Acid Hikma :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Uncommon |
Acute kidney injury | Uncommon |
Acute phase reaction | Common |
Anaemia | Common |
Anaphylactic reactions | Uncommon |
Anaphylactic shock | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Anxiety | Uncommon |
Arrhythmia | Rare |
Arthralgia (Pain joint) (Joint ache) | Common |
Arthritis | Rare |
Asthenia | Uncommon |
Atrial fibrillation | Uncommon |
Atypical femur fracture | Rare |
Blood creatinine increased | Common |
Blood urea increased | Common |
Bone pain | Common |
Bradycardia | Rare |
Bronchospasm | Uncommon |
Chest pain | Uncommon |
Chills | Common |
Circulatory collapse | Uncommon |
Confusional state | Rare |
Conjunctivitis | Common |
Constipation | Uncommon |
Cough | Uncommon |
Decreased appetite | Common |
Diarrhoea (Diarrhea) | Uncommon |
Dizziness | Uncommon |
Dry mouth (Xerostomia) | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Uncommon |
Dyspnoea (dyspnea) | Uncommon |
Episcleritis | Very rare |
Fatigue | Common |
Flushing | Common |
Haematuria (Hematuria) | Uncommon |
Headache | Common |
Hyperaesthesia | Uncommon |
Hyperhidrosis | Uncommon |
Hyperkalaemia | Rare |
Hypernatraemia | Rare |
Hypersensitivity | Uncommon |
Hypertension | Uncommon |
Hypocalcaemia | Common |
Hypoesthesia | Uncommon |
Hypokalaemia | Uncommon |
Hypomagnesaemia | Uncommon |
Hypophosphataemia | Very Common |
Hypotension | Uncommon |
Influenza-like illness | Common |
Injection site induration | Uncommon |
Injection site irritation | Uncommon |
Injection site pain | Uncommon |
Injection site reaction | Uncommon |
Injection site swelling | Uncommon |
Interstitial pneumonitis | Rare |
Joint swelling | Rare |
Leucopenia (Leukopenia) | Uncommon |
Malaise | Common |
Muscle spasms | Uncommon |
Myalgia | Common |
Nausea | Common |
Oedema peripheral | Uncommon |
Osteonecrosis | Not known |
Osteonecrosis of the jaw | Uncommon |
Pain | Common |
Pancytopenia | Rare |
Paraesthesia (paresthesia) | Uncommon |
Parophthalmia | Uncommon |
Proteinuria | Uncommon |
Pruritus | Uncommon |
Pyrexia | Common |
Rash erythematous | Uncommon |
Rash macular | Uncommon |
Renal impairment | Common |
scleritis | Uncommon |
Seizures | Very rare |
Skin rash | Uncommon |
Sleep disorder (Sleep disturbance) | Uncommon |
Somnolence | Uncommon |
Stomatitis | Uncommon |
Syncope | Uncommon |
Tetany | Very rare |
Thrombocytopenia (Thrombopenia) | Uncommon |
Tremor | Uncommon |
Urticaria | Uncommon |
Uveitis | Rare |
Vision blurred | Uncommon |
Vomiting | Common |
Weight increased (weight gain) | Uncommon |
Zoledronic Acid Hikma :
NB : Products With Same Indication |
Different Units By MoH Code
Zoledronic Acid Hikma MoH 5894 :
Form | Powder for solution for infusion |
Packaging | Bottle |
Package Size | 1x5ml |
Strength | 4mg |
NSSF | ✘ |
Quarantine | ✔ |
Reg. Number | 218666/10 |
Submission date | 01/01/2010 |
Registration Year | 2010 |
Archived Date | 03/05/2023 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 1 Vial | |
● Public Price: | 1032 AED | ( 24,934,152.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1032 AED | ( 24,934,152.00 LBP ) |
● Pharmacy Price: | 1032 AED | ( 24934152 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1x5ml | |
● Public Price: | 173.62 JOD | ( 21,740,870.02 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 173,62 JOD | ( 21,663,233.00 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 25/05/2020 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 10x5ml | |
● Public Price: | 1270.24 EUR | ( 123,055,770.24 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 127,024 EUR | ( 12,303,252.00 LBP ) |
● Exfactory Price: | 769.65 EUR | |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands |
● Package Size: | 1x5ml |
● Reference: | Zorginstituut Nederland |
● Pricing Date: | 15/06/2019 |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File